For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Morphic Therapeutic, Inc.

USPTO Granted Patents = 17

EPO Patents = 7

Trademarks = 2

Forward Citations = 63

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Fu-Yang Lin (17 out of 17 patents)

Blaise S Lippa (17 out of 22 patents)

Dawn M Troast (17 out of 17 patents)

4. Aleksey I Gerasyuto (17 out of 25 patents)

5. Bruce Nelsen Rogers (17 out of 49 patents)

6. Matthew Gregory Bursavich (17 out of 25 patents)

7. Bryce Alden Harrison (17 out of 21 patents)

8. Kyle D Konze (16 out of 16 patents)

9. Kristopher N Hahn (14 out of 14 patents)

10. Mats A Svensson (14 out of 14 patents)

11. Alexey Alexandrovich Lugovskoy (10 out of 52 patents)

12. Cheng Zhong (10 out of 15 patents)

13. Byungchan Kim (9 out of 10 patents)

14. Tyler Day (9 out of 9 patents)

15. Brian Sosa (8 out of 8 patents)

17 patents: Sort by Forward Citations

1. 12552786 - Inhibitors of αvβ6 integrin (2026-02-17),

2. 12528803 - Inhibitors of αvβ6 integrin (2026-01-20),

3. 12459942 - Inhibiting (α-v)(β-6) integrin (2025-11-04),

4. 12415796 - Inhibitors of (αv)(β6) integrin (2025-09-16),

5. 12221416 - Antagonists of human integrin α4β7 (2025-02-11),

6. 12145935 - Inhibitors of (α-v)(β-6) integrin (2024-11-19),

7. 11827621 - Inhibitors of (α-v)(β-6) integrin (2023-11-28),

8. 11795167 - Inhibitors of (α-v)(β-6) integrin (2023-10-24),

9. 11739087 - Inhibiting (α-v)(β-6) integrin (2023-08-29),

10. 11370773 - Inhibiting human integrin (alpha-4) (beta-7) (2022-06-28),

11. 11174228 - Antagonists of human integrin (α4)(β7) (2021-11-16),

12. 11104661 - Inhibiting human integrin (α-4) (β-7) (2021-08-31),

13. 11046685 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),

14. 11046669 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),

15. 11040955 - Inhibitors of (alpha-v)(beta-6) integrin (2021-06-22),

Morphic Therapeutic, Inc. is a biotechnology company that focuses on developing oral integrin therapies for serious chronic diseases. The company's proprietary platform enables the discovery and optimization of small molecule integrin inhibitors, providing novel treatment options for patients. With a strong pipeline and cutting-edge research, Morphic Therapeutic is dedicated to transforming the field of integrin biology and advancing personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Morphic Therapeutic, Inc.

17 Patents

#86 in Waltham, MA

#1,149 in Massachusetts

#18,849 in US

#35,819 in the World

Waltham, MA, United States of America

Morphic Therapeutic, Inc.

Forward Citations = 63

30 inventors:

Fu-Yang Lin (17 out of 17 patents)

Blaise S Lippa (17 out of 22 patents)

Dawn M Troast (17 out of 17 patents)

4. Aleksey I Gerasyuto (17 out of 25 patents)

5. Bruce Nelsen Rogers (17 out of 49 patents)

Please report any incorrect information to [email protected]

Loading…